Vigil Neuroscience Inc has a consensus price target of $18.33 based on the ratings of 9 analysts. The high is $24 issued by HC Wainwright & Co. on June 28, 2024. The low is $4 issued by Morgan Stanley on December 19, 2023. The 3 most-recent analyst ratings were released by Wedbush, Wedbush, and HC Wainwright & Co. on July 11, 2024, June 28, 2024, and June 28, 2024, respectively. With an average price target of $23.33 between Wedbush, Wedbush, and HC Wainwright & Co., there's an implied 456.88% upside for Vigil Neuroscience Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/11/2024 | Buy Now | 448.93% | Wedbush | Laura Chico | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert |
06/28/2024 | Buy Now | 448.93% | Wedbush | Laura Chico | $22 → $23 | Maintains | Outperform | Get Alert |
06/28/2024 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | $24 → $24 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | → $24 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 425.06% | Wedbush | Laura Chico | → $22 | Reiterates | Outperform → Outperform | Get Alert |
04/19/2024 | Buy Now | 448.93% | JMP Securities | Jason Butler | → $23 | Reiterates | Market Outperform → Market Outperform | Get Alert |
04/18/2024 | Buy Now | 448.93% | JMP Securities | Jason Butler | → $23 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/27/2024 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | $24 → $24 | Maintains | Buy | Get Alert |
12/19/2023 | Buy Now | -4.53% | Morgan Stanley | Jeffrey Hung | $13 → $4 | Downgrade | Equal-Weight → Underweight | Get Alert |
11/17/2023 | Buy Now | 448.93% | Wedbush | Laura Chico | → $23 | Reiterates | Outperform → Outperform | Get Alert |
11/08/2023 | Buy Now | 448.93% | Wedbush | Laura Chico | → $23 | Reiterates | Outperform → Outperform | Get Alert |
10/18/2023 | Buy Now | 448.93% | JMP Securities | Jason Butler | → $23 | Initiates | → Market Outperform | Get Alert |
09/14/2023 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | → $24 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | → $24 | Reiterates | Buy → Buy | Get Alert |
04/03/2023 | Buy Now | 448.93% | Wedbush | Laura Chico | → $23 | Reiterates | → Outperform | Get Alert |
03/31/2023 | Buy Now | 258% | Mizuho | Graig Suvannavejh | → $15 | Initiates | → Buy | Get Alert |
03/27/2023 | Buy Now | 210.26% | Morgan Stanley | Matthew Harrison | $12 → $13 | Maintains | Equal-Weight | Get Alert |
03/22/2023 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | → $24 | Reiterates | → Buy | Get Alert |
11/14/2022 | Buy Now | 186.4% | Morgan Stanley | Matthew Harrison | $11 → $12 | Maintains | Equal-Weight | Get Alert |
11/11/2022 | Buy Now | 353.46% | Guggenheim | Yatin Suneja | $22 → $19 | Maintains | Buy | Get Alert |
09/16/2022 | Buy Now | 353.46% | Wedbush | Laura Chico | → $19 | Initiates | → Outperform | Get Alert |
08/29/2022 | Buy Now | 472.79% | HC Wainwright & Co. | Andrew Fein | → $24 | Initiates | → Buy | Get Alert |
05/17/2022 | Buy Now | 162.53% | Morgan Stanley | Matthew Harrison | $17 → $11 | Maintains | Equal-Weight | Get Alert |
02/01/2022 | Buy Now | 472.79% | Stifel | Paul Matteis | → $24 | Initiates | → Buy | Get Alert |
02/01/2022 | Buy Now | 305.73% | Morgan Stanley | Matthew Harrison | → $17 | Initiates | → Equal-Weight | Get Alert |
02/01/2022 | Buy Now | 377.33% | Jefferies | Andrew Tsai | → $20 | Initiates | → Buy | Get Alert |
The latest price target for Vigil Neuroscience (NASDAQ:VIGL) was reported by Wedbush on July 11, 2024. The analyst firm set a price target for $23.00 expecting VIGL to rise to within 12 months (a possible 448.93% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Vigil Neuroscience (NASDAQ:VIGL) was provided by Wedbush, and Vigil Neuroscience reiterated their outperform rating.
There is no last upgrade for Vigil Neuroscience
The last downgrade for Vigil Neuroscience Inc happened on December 19, 2023 when Morgan Stanley changed their price target from $13 to $4 for Vigil Neuroscience Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vigil Neuroscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vigil Neuroscience was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
While ratings are subjective and will change, the latest Vigil Neuroscience (VIGL) rating was a reiterated with a price target of $23.00 to $23.00. The current price Vigil Neuroscience (VIGL) is trading at is $4.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.